BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 8, 2020
View Archived Issues
Noncoding mutations contribute to heart disease
Read More
Good vs. evil in the synovial joint
Read More
Topline data presented from global phase II trial of SEP-4199 in bipolar I depression
Read More
Discovery of novel HDAC6 selective inhibitors with potent preclinical activity
Read More
ImmunoGen presents next-generation FR-alpha-targeting ADC, IMGN-151
Read More
Dana-Farber Cancer Institute presents new MAPK9 inhibitors
Read More
Theravance Biopharma patents TGFR-1 inhibitors
Read More
Prelude Therapeutics discloses Mcl-1 inhibitors
Read More
RemeGen describes new angiogenesis inhibitors
Read More
ImmuneOnco Biopharmaceuticals divulges anti-PD-L1 and anti-VEGF compounds
Read More
Enrollment completed in pivotal DERBY and OAKS studies of pegcetacoplan
Read More
Novel innovative COVID-19 drug testing platform launched in the U.K.
Read More
Cabaletta Bio and Artisan Bio collaborate to develop next-generation CAAR T-cell therapies
Read More
Engineered interleukin-18 ignores tumors' defenses
Read More
Potent, orally available AXL inhibitor DW-17401 reduces xenograft tumor growth
Read More
Anti-CCR8 MAb BMS-986340 shows promise as cancer immunotherapeutic
Read More
Allogeneic anti-PTK7 CAR-T cells may allow safe access to the anticancer target
Read More
New phase I trial evaluates Curis' IRAK-4 kinase inhibitor CA-4948 in AML and MDS
Read More
Pivotal study of F-627 for chemotherapy-induced neutropenia meets primary and secondary endpoints
Read More
Anti-HER3 antibody shows efficacy in vivo against NRG1 fusion-bearing tumors
Read More
Inqovi approved in U.S. and Canada for MDS
Read More
InMed begins second phase I trial of INM-755 for epidermolysis bullosa
Read More
GSK and Medicago collaborate on adjuvanted COVID-19 candidate vaccine
Read More
STK-001 studied for Dravet syndrome in new phase I/II study
Read More
Corvus begins phase I study of CPI-006 in COVID-19
Read More
Hepion reports promising preclinical data with CRV-431 supporting potential for COVID-19
Read More